PL3981390T3 - Kompozycja farmaceutyczna lakozamidu i jego preparat farmaceutyczny - Google Patents

Kompozycja farmaceutyczna lakozamidu i jego preparat farmaceutyczny

Info

Publication number
PL3981390T3
PL3981390T3 PL20819422.5T PL20819422T PL3981390T3 PL 3981390 T3 PL3981390 T3 PL 3981390T3 PL 20819422 T PL20819422 T PL 20819422T PL 3981390 T3 PL3981390 T3 PL 3981390T3
Authority
PL
Poland
Prior art keywords
pharmaceutical
lacosamide
pharmaceutical composition
preparation
pharmaceutical preparation
Prior art date
Application number
PL20819422.5T
Other languages
English (en)
Inventor
Shaoqiong LYU
Shoufeng Li
Xun ZHENG
Zhongqin Wang
Original Assignee
Shanghai Aucta Pharmaceuticals Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73609344&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL3981390(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
US case filed in New Jersey District Court litigation https://portal.unifiedpatents.com/litigation/New%20Jersey%20District%20Court/case/1%3A26-cv-02954 Source: District Court Jurisdiction: New Jersey District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License.
US case filed in New Jersey District Court litigation https://portal.unifiedpatents.com/litigation/New%20Jersey%20District%20Court/case/3%3A26-cv-02954 Source: District Court Jurisdiction: New Jersey District Court "Unified Patents Litigation Data" by Unified Patents is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Shanghai Aucta Pharmaceuticals Co., Ltd. filed Critical Shanghai Aucta Pharmaceuticals Co., Ltd.
Publication of PL3981390T3 publication Critical patent/PL3981390T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Addiction (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL20819422.5T 2019-06-06 2020-06-05 Kompozycja farmaceutyczna lakozamidu i jego preparat farmaceutyczny PL3981390T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201910490175 2019-06-06
CN201911189496 2019-11-28
PCT/CN2020/094556 WO2020244615A1 (zh) 2019-06-06 2020-06-05 一种拉考沙胺药物组合物及其药物制剂

Publications (1)

Publication Number Publication Date
PL3981390T3 true PL3981390T3 (pl) 2026-05-11

Family

ID=73609344

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20819422.5T PL3981390T3 (pl) 2019-06-06 2020-06-05 Kompozycja farmaceutyczna lakozamidu i jego preparat farmaceutyczny

Country Status (13)

Country Link
US (2) US11337943B2 (pl)
EP (2) EP3981390B1 (pl)
CN (3) CN114173763A (pl)
CA (1) CA3148705A1 (pl)
DK (1) DK3981390T3 (pl)
ES (1) ES3061097T3 (pl)
FI (1) FI3981390T3 (pl)
HR (1) HRP20260206T1 (pl)
LT (1) LT3981390T (pl)
PL (1) PL3981390T3 (pl)
PT (1) PT3981390T (pl)
SI (1) SI3981390T1 (pl)
WO (1) WO2020244615A1 (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12042474B2 (en) 2019-06-06 2024-07-23 Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide pharmaceutical composition and dosage form thereof
CN114699368B (zh) * 2022-04-12 2023-05-19 南京海纳医药科技股份有限公司 一种拉考沙胺口服溶液及其制备方法
CN114983973B (zh) * 2022-05-31 2023-05-05 石家庄四药有限公司 一种乌拉地尔缓释胶囊及其制备方法
CN117323297A (zh) * 2023-10-12 2024-01-02 海南卫康制药(潜山)有限公司 一种拉考沙胺干糖浆的制备方法
US12303604B1 (en) 2024-10-16 2025-05-20 Currax Pharmaceuticals Llc Pharmaceutical formulations comprising naltrexone and/or bupropion
US12478587B1 (en) * 2025-02-06 2025-11-25 Shanghai Aucta Pharmaceuticals Co., Ltd. Formulation for lacosamide

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX350056B (es) * 2009-11-03 2017-08-25 Lupin Ltd Formulacion de liberacion modificada de lacosamida.
WO2011101863A2 (en) * 2010-02-19 2011-08-25 Cadila Healthcare Limited Extended release pharmaceutical compositions of lacosamide
JP6027539B2 (ja) * 2010-12-02 2016-11-16 ウーツェーベー ファルマ ゲーエムベーハーＵｃｂ Ｐｈａｒｍａ Ｇｍｂｈ ラコサミドの１日１回投与用製剤
CN102920663B (zh) * 2011-08-08 2015-02-11 丽珠医药集团股份有限公司 一种泛昔洛韦缓释微丸、其制备方法及应用
CN102670544B (zh) * 2012-06-05 2016-04-06 石家庄四药有限公司 一种拉科酰胺缓释片及其制备方法
CN102885796A (zh) * 2012-07-30 2013-01-23 永光制药有限公司 一种治疗癫痫的拉科酰胺片剂及其制备方法
WO2015120110A2 (en) * 2014-02-07 2015-08-13 Auspex Pharmaceuticals, Inc. Novel pharmaceutical formulations
US20180021307A1 (en) * 2015-02-20 2018-01-25 Ucb Biopharma Sprl Combination Treatment
EP3397253A1 (en) * 2015-12-30 2018-11-07 Adamas Pharmaceuticals, Inc. Methods and compositions for the treatment of seizure-related disorders
CN105534949A (zh) * 2016-01-06 2016-05-04 北京修正创新药物研究院有限公司 一种盐酸度洛西汀的肠溶微丸制剂
CN106619531A (zh) * 2016-10-02 2017-05-10 上海奥科达生物医药科技有限公司 一种稳定的口服缓释混悬剂的制备方法
KR102083241B1 (ko) * 2018-02-14 2020-03-02 환인제약 주식회사 라코사미드를 함유하는 약제학적 서방성 조성물

Also Published As

Publication number Publication date
US20210283076A1 (en) 2021-09-16
EP3981390A4 (en) 2023-01-25
DK3981390T3 (da) 2026-02-09
HRP20260206T1 (hr) 2026-04-24
SI3981390T1 (sl) 2026-04-30
EP3981390A1 (en) 2022-04-13
LT3981390T (lt) 2026-03-10
CN112043681B (zh) 2022-04-12
US11883374B2 (en) 2024-01-30
US20220280456A1 (en) 2022-09-08
EP4706643A2 (en) 2026-03-11
WO2020244615A1 (zh) 2020-12-10
ES3061097T3 (en) 2026-03-31
CA3148705A1 (en) 2020-12-10
CN114404393A (zh) 2022-04-29
US11337943B2 (en) 2022-05-24
CN114404393B (zh) 2023-02-24
CN114173763A (zh) 2022-03-11
EP3981390B1 (en) 2025-12-03
PT3981390T (pt) 2026-02-10
FI3981390T3 (fi) 2026-02-06
CN112043681A (zh) 2020-12-08

Similar Documents

Publication Publication Date Title
IL287445A (en) A quinazoline compound and its pharmacologic use
SI3981390T1 (sl) Farmacevtska sestava lakozamida in njegova farmacevtska priprava
GB202008961D0 (en) Pharmaceutical composition
ZA202105586B (en) Pharmaceutical delivery compositions and uses thereof
IL287628B1 (en) Injectable pharmaceutical compounds and their uses
IL283938B2 (en) History of oxypyrimidinyl-methyl-benzamide and their deuterated forms and pharmaceutical preparations containing them
GB201911517D0 (en) Pharmaceutical composition
EP3697411A4 (en) NEW PHARMACEUTICAL COMPOSITION AND ITS USE
IL288645A (en) Conjugated saponin and vaccine or a pharmaceutical composition containing it
ZA202006541B (en) Pharmaceutical composition comprising brexpiprazole
IL290469A (en) Oral pharmaceutical preparation
PL3908321T3 (pl) Kompozycja farmaceutyczna
ZA202008034B (en) Ivosidenib forms and pharmaceutical compositions
GB2595140B (en) Flupentixol/melitracen pharmaceutical composition and preparation thereof
EP3813842A4 (en) PHARMACEUTICAL COMPOSITION AND MANUFACTURING PROCESS THEREOF
IL285728A (en) Pharmaceutical composition
ZA202100166B (en) Composition comprising glycyrrhin and cosmetic and pharmaceutical uses thereof
GB2595406B (en) Pharmaceutical composition containing acetominophen and ibuprofen
IL276783A (en) The composition and pharmaceutical compound containing it
PL3949952T3 (pl) Kompozycja farmaceutyczna
ZA202104261B (en) Combination pharmaceutical compositions and methods thereof
IL292646A (en) Pharmaceutical combination and its use
HUE064434T2 (hu) Gyógyászati készítmény
SG11202010069SA (en) Dipeptide and pharmaceutical composition containing same
HUP1800273A2 (en) Stable pharmaceutical compositions and process for the preparation thereof